Home » Stocks » NMRD

Nemaura Medical Inc. (NMRD)

Stock Price: $6.99 USD -0.08 (-1.13%)
Updated Mar 8, 2021 4:00 PM EST - Market closed
Market Cap 166.29M
Revenue (ttm) n/a
Net Income (ttm) -5.47M
Shares Out 22.92M
EPS (ttm) -0.25
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day March 8
Last Price $6.99
Previous Close $7.07
Change ($) -0.08
Change (%) -1.13%
Day's Open 7.09
Day's Range 6.90 - 7.40
Day's Volume 52,040
52-Week Range 3.12 - 16.50

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Proactive Investors - 2 weeks ago

Nemaura Medical Inc (NASDAQ:NMRD) has reported that it ended its third quarter with $14,959,785 in cash on the books as of December 31, 2020, up from $1,067,663 at the same stage a year earlie...

GlobeNewsWire - 2 weeks ago

Loughborough, England, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializin...

Proactive Investors - 3 weeks ago

Nemaura Medical Inc (NASDAQ:NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coachin...

GlobeNewsWire - 3 weeks ago

Loughborough, England, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializi...

InvestorPlace - 1 month ago

Nemaura Medical (NMRD) stock is on the rise Monday with heavy trading despite a lack of news concerning the medical company. The post NMRD Stock: 8 Things to Know About Biopharma Nemaura Medic...

GlobeNewsWire - 1 month ago

Loughborough, England, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializi...

GlobeNewsWire - 2 months ago

LOUGHBOROUGH, England, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializi...

GlobeNewsWire - 2 months ago

LOUGHBOROUGH, England, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializin...

GlobeNewsWire - 3 months ago

LOUGHBOROUGH, England, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializin...

GlobeNewsWire - 3 months ago

LOUGHBOROUGH, England, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializin...

GlobeNewsWire - 4 months ago

LOUGHBOROUGH, England, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializin...

GlobeNewsWire - 5 months ago

Clinically proven app from Healthimation , LLC , to be paired with Company’s pro BEAT ™ non-invasive CGM system solution to offer convenient and effective management of pre-diabetes an...

Business Wire - 5 months ago

LOUGHBOROUGH, England--(BUSINESS WIRE)--Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive we...

Business Wire - 6 months ago

LOUGHBOROUGH, England--(BUSINESS WIRE)--Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable diagn...

Business Wire - 6 months ago

LOUGHBOROUGH, England--(BUSINESS WIRE)--Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable diagn...

Business Wire - 6 months ago

LOUGHBOROUGH, England--(BUSINESS WIRE)--Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable diagn...

Business Wire - 6 months ago

LOUGHBOROUGH, England--(BUSINESS WIRE)--Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company commercializing sugarBEAT®, a non-invasive and flexible continuous glucose...

Benzinga - 7 months ago

Nemaura Medical (NASDAQ: NMRD) shares are trading lower on Tuesday after the company filed for a common stock offering of 1.6 million shares.

Business Wire - 7 months ago

LOUGHBOROUGH, England--(BUSINESS WIRE)--Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable diagno...

Business Wire - 7 months ago

LOUGHBOROUGH, England--(BUSINESS WIRE)--Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable diagno...

Business Wire - 7 months ago

LOUGHBOROUGH, England--(BUSINESS WIRE)--Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable diagn...

Business Wire - 7 months ago

LOUGHBOROUGH, England--(BUSINESS WIRE)--Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable diagn...

Business Wire - 8 months ago

LOUGHBOROUGH, England--(BUSINESS WIRE)--Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable diagn...

Business Wire - 8 months ago

LOUGHBOROUGH, England--(BUSINESS WIRE)--Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company commercializing sugarBEAT®, a non-invasive and flexible continuous glucose...

Business Wire - 8 months ago

LOUGHBOROUGH, England--(BUSINESS WIRE)--Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable diagn...

Business Wire - 8 months ago

LOUGHBOROUGH, England--(BUSINESS WIRE)--Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable diagn...

GuruFocus - 11 months ago

There are a number of medical technology companies  that have gained momentum in an otherwise pessimistic market amid the Covid-19 pandemic.

GuruFocus - 11 months ago

The company's continuous glucose monitor is a potential breakthrough in the diabetes diagnostics space, and also the reason why its stock has gained momentum

GlobeNewsWire - 1 year ago

Loughborough, England, Feb. 11, 2020 (GLOBE NEWSWIRE) --   Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company commercializing sugarBEAT®, a non-invasive and flex...

GlobeNewsWire - 1 year ago

Loughborough, England, Dec. 20, 2019 (GLOBE NEWSWIRE) --  Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company commercializing sugarBEAT®, a non-invasive and flexible continuou...

GlobeNewsWire - 1 year ago

Nemaura and Changing Health to provide innovative digital education and personalized coaching to enhance outcomes for people with diabetes and prediabetes Nemaura and Changing Health to provid...

GlobeNewsWire - 1 year ago

BEAT® Diabetes utilizes SugarBEAT® CGM data to provide holistic coaching services via user-friendly app to enhance outcomes for diabetic and pre-diabetic patients  BEAT® Diabetes utilizes Suga...

GlobeNewsWire - 1 year ago

Loughborough, England, Dec. 04, 2019 (GLOBE NEWSWIRE) --  Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company focused on the commercialization of SugarBEAT® as a ...

GlobeNewsWire - 1 year ago

Loughborough, England, Nov. 11, 2019 (GLOBE NEWSWIRE) --  – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company focused on the commercialization of SugarBEAT® as...

GlobeNewsWire - 1 year ago

Loughborough, England , Sept. 12, 2019 (GLOBE NEWSWIRE) -- Loughborough, England – September 12, 2019 – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company f...

About NMRD

Nemaura Medical, a medical technology company, discovers, develops, and commercializes diagnostic medical devices. The company provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. It has a license agreement with Healthimation, LLC, which licenses the company to make, have made, use, offer to sell, sell, and import intensive medical diabetes and weight management program for Type 2 diabetes, prediabetes, and general wellness; t... [Read more...]

Industry
Medical Devices
Founded
2009
CEO
Dewan Chowdhury
Employees
17
Stock Exchange
NASDAQ
Ticker Symbol
NMRD
Full Company Profile

Financial Performance

Financial Statements